Genmab A/S (GMAB) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Genmab A/s.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.657 Hello and welcome to the GenMAP's first quarter 2026 financial results conference call. 00:00:05.657 -- 00:00:08.921 As a reminder, this conference call is being recorded. 00:00:08.921 -- 00:00:13.166 During this telephone conference, you may be presented with forward-looking statements 00:00:13.166 -- 00:00:18.291 that include words such as beliefs, anticipates, plans or expects. 00:00:18.291 -- 00:00:22.736 Actual results may differ materially, for example, as a result of delayed or unsuccessful 00:00:22.736 -- 00:00:28.002 development projects. GenMAP is not under any obligation to update statements regarding 00:00:28.002 -- 00:00:33.349 the future, nor to confirm such statements in relation to actual results, unless 00:00:33.349 -- 00:00:38.376 this is required by law. Please also note that GenMap may hold 00:00:38.376 -- 00:00:44.284 your personal data as indicated by you as a part of our investor relations outreach activities 00:00:44.284 -- 00:00:47.528 in order to update you on GenMap going forward. 00:00:47.528 -- 00:00:53.016 Please refer to our website for more information on GenMap and our privacy policy. 00:00:53.016 -- 00:00:57.041 I would like to hand the conference over to our first speaker today, Jan van der Winkel. 00:00:57.041 -- 00:00:59.382 Please go ahead. 00:00:59.515 -- 00:01:03.519 Hello, and welcome to our financial results call for the first quarter of 2026. 00:01:03.519 -- 00:01:05.201 With 00:01:05.201 -- 00:01:10.026 me today is our Chief Financial Officer, Anthony Pagano, and our Chief Commercial Officer, 00:01:10.026 -- 00:01:15.032 Brad Bailey. For the Q&A, we will be joined by our Chief Medical Officer, Tai 00:01:15.032 -- 00:01:19.734 Yamadi, and our Chief Development Officer, Judith Klimowski. 00...